Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Accelerating datacenter and custom AI silicon adoption via Compute Subsystems (CSS) and Neoverse architectures.
Royalty revenue annual growth decelerating below 10% YoY over the next 12 months.
Arm Holdings plc (ARM) is rated Sell with an intrinsic fair value of $54.92 per share and a potential value of $91.94 per share, indicating an implied return of -81.36% from the share price of $294.65 as of September 29, 2026 as an extreme forward valuation multiple of 151.52x disconnects from near-term smartphone royalty deceleration and high capital intensity.35
This premium implies annual EPS growth compounding above 50% through 2031, which clashes with operational evidence. Smartphone market softness across lower, mid, and upper tiers has led management to guide Q2 FY2027 royalty growth down to 13%. Concurrently, capital intensity has escalated as FY2026 capital expenditures surged to $545M (2.31x D&A and 11.08% of ), up from $219M in FY2025 and $143M in FY2024. Share-based compensation of $1,052M in FY2026 (21.38% of revenue) also exceeded total GAAP of $904M, diluting per-share economic gains.
Despite this severe valuation dislocation, Arm's underlying economic moat is rated Wide (score 9.0). The business commands 92.48% gross margins ($4,550M gross profit on $4,920M revenue), insulated by deep developer lock-in and instruction set architecture ubiquity. In FY2026, royalty revenue reached $2,613M (53.1% of revenue), supported by the ongoing architectural shift to Armv9, which commands approximately twice the royalty rate of v8. Licensing revenue expanded to $2,307M, driven by turnkey Compute Subsystems (CSS). In the data center, Neoverse core deployments crossed 1.5 billion units, demonstrated by Google Axion adoption and pipeline demand exceeding $2B across FY2027-FY2028. The balance sheet remains pristine with $2,751M in cash and equivalents against total debt of just $485M.2357
Our valuation synthesis assigns primary weight (70% combined) to Forward Earnings ($85.23) and Multi-Stage Moat Fade ($44.97), supported by FCFF DCF ($18.70, 15% weight) and Owner Earnings ($23.97, 10% weight). When measured against established semiconductor peers such as ASML (forward P/E of 31.06x) and MPWR (38.63x), Arm's 151.52x multiple exposes equity holders to substantial multiple contraction risk. Furthermore, customer concentration remains elevated, with the top three customers generating 42% of revenue ($2,066M), led by the largest customer at 16% ($787.2M), giving key counterparties leverage. With the stock price trading at a 436.5% premium over our fair value of $54.92, and fair value sitting 81.36% below the market price, we assign a Sell rating and advise investors to eliminate exposure.47
Transition from legacy v8 to v9 architecture commands approximately double the royalty rate per chip across mobile and infrastructure, driving royalty revenue of $2,613M in FY2026 with management reaffirming 20%+ royalty growth for FY2028-FY2029.57
Neoverse datacenter core deployments surpassed 1.5 billion units, demonstrated by Google Axion deployment and pipeline demand exceeding $2B across FY2027-FY2028.5
Asset-light IP licensing architecture generates 92.48% gross margins ($4,550M on $4,920M revenue) and holds $2,751M in cash against $485M in debt, fully self-funding compute transformation.23
Sell. While Arm commands an exceptional Wide economic moat anchored by instruction set ubiquity and v9 royalty expansion, the valuation at a share price of $294.65 as of September 29, 2026 reflects an unsustainable forward P/E of 151.52x and discounts perfection. With composite intrinsic fair value estimated at $54.92 per share against a potential value of $91.94, shares carry an implied return of -81.36%, rendering the risk-reward profile deeply unfavorable.
Arm Holdings plc provides software development tools and a range of services to companies developing chips based on its products.
Our stress test models a combined macro-geopolitical shock: prolonged smartphone replacement cycle stagnation capping royalty growth at 8% YoY, heightened export restrictions reducing Chinese licensing revenues by 50% from $874M to $437M, and persistent transformation capital intensity where capex remains elevated above 10% of revenue. Under this confluence of shocks, FY2028 revenue fails to reach consensus of $8,236M, operating margins compress toward 18% rather than expanding toward 28%, and forward valuation multiples contract sharply from 151.52x toward the semiconductor peer median of 31.06x. This structural compression drives equity value toward the low end of our intrinsic range of $25.42, representing a catastrophic drawdown from current trading levels of $294.65.
In the bear case, consumer smartphone replacement cycles remain frozen across all pricing tiers, restricting royalty growth to single digits. Stricter geopolitical export restrictions impair Chinese licensing revenues, while ongoing design complexity keeps capital expenditures and SBC persistently elevated. Multiple compression ensues, driving equity values toward the conservative lower bounds of architectural intrinsic value.
Management lowered Q2 royalty growth expectations to 13% as weakness across lower, mid, and upper smartphone tiers persists. Royalty growth decelerating below 10% YoY would invalidate the core Armv9 pricing premium thesis, inflicting an estimated -28.5% fair value impairment.5
The five developments that would weaken our investment case.
Deceleration below 10% indicates stalling Armv9 architectural penetration and consumer smartphone demand weakness.
Current:13% guided for Q2 FY2027
Alert if< 10.0% YoY
Arm Holdings occupies an unparalleled bottleneck position in the semiconductor industry, maintaining a Wide economic moat anchored by pervasive instruction set architecture (ISA) ubiquity, entrenched developer switching costs, and powerful network effects across mobile, datacenter, and edge computing ecosystems. Over 300 billion chips have been deployed on Arm architecture, establishing a software stack and compiler ecosystem that creates virtually insurmountable friction against displacement. In FY2026, Arm demonstrated the financial strength of this asset-light licensing model by generating $4,920M in consolidated revenue with gross profit of $4,550M (92.48% gross margin).
The durability of Arm's economic moat is currently expanding as the business transitions licensees from legacy Armv8 to the Armv9 architecture. Armv9 commands approximately double the royalty rate per chip, allowing Arm to generate double-digit royalty growth despite volume stagnation across global smartphone tiers. Furthermore, Arm's evolution into turnkey Compute Subsystems (CSS) pre-integrates memory controllers, interconnects, and compute blocks, compressing licensee time-to-market by up to a year and creating deeper architectural dependency among hyperscale cloud providers and custom ASIC developers.
Datacenter and cloud AI infrastructure represent the primary vector of moat widening. Deployments of Arm Neoverse cores have surpassed 1.5 billion units, gaining substantial share across tier-one hyperscalers including Google's Axion processor. While customer concentration remains notable—with the top three customers representing 42% of revenue —the mutual dependency between Arm and its anchor licensees reinforces long-term multi-generational contract commitments.
While FY2026 reported return on invested capital was 9.38% due to elevated transformation capital expenditures of $545M and heavy R&D reinvestment, Arm's structural gross margins of 92.48% ($4,550M gross profit on $4,920M revenue) indicate that incremental returns on capital remain exceptional. Cost of equity is 16.22% under current beta conditions (normalized cost of equity is 11.55%), and normalized ROIC is projected to expand well above 25% as Armv9 royalty expansion scales through FY2028-FY2031.2
Each lens answers a different valuation question. Only included lenses set Fair value; floors and diagnostics provide context.
The highlighted cell is Fair value when every assumption sits at its base level ($54.92). Each row and column shows what Fair value becomes when one assumption moves.
Free cash flow to the firm stays positive in the first projected year at $736.9M after modeled reinvestment of $396.8M, with terminal value at 67.2% of enterprise value. A sudden drop in free cash flow is not projected unless capital spending relative to revenue, reinvestment, or gross margin resets materially.
The base case represents the house modal path where Arm successfully transitions licensees to the v9 architecture, achieving double-digit royalty growth despite a mature smartphone market. Capex gradually normalizes from FY2026 peak levels ($545M), allowing free cash flow conversion to improve over time. Consensus FY2028 EPS of $3.05 is achieved, and long-term operating margins reach 36.0%, yielding an intrinsic fair value of $54.92.135
Even in a blowout earnings scenario exceeding the top of management guidance across revenue and EPS, the shares trading at $294.65 reflect an extreme premium over house Fair value of $54.92, meaning operational beats cannot bridge the valuation gap.
Meeting Q2 FY2027 guidance ($1.38B ±$50M revenue and 13% royalty growth) merely confirms existing baseline assumptions while leaving the stock exposed to severe multiple compression from an unsustainable forward P/E of 151.52x.
A miss indicates that smartphone tier weakness is overwhelming Armv9 royalty expansion or that licensing tape-outs are stalling, accelerating equity multiple de-rating toward peer group medians (31.06x).
Earnings quality reflects a significant divergence between GAAP results and non-GAAP or operating cash measures. In FY2026, GAAP net income of $904M was significantly smaller than total share-based compensation of $1,052M (21.38% of revenue). While operating cash flow appears robust at $1,524M, it is heavily subsidized by share dilution rather than pure cash profitability. Furthermore, free cash flow of $979M is curtailed by elevated transformation capital expenditures of $545M, highlighting that cash generation per share remains substantially lower than headline operating profit implies.3
Validates whether the transition to the latest architecture generation commands the expected substantial royalty pricing premium to offset sluggish smartphone end-market unit volumes.
Arm generated $1,524M in operating cash flow in FY2026, but free cash flow conversion was restricted to $979M due to capital expenditures surging to $545M (2.31x D&A and 11.08% of revenue). Furthermore, FY2026 share-based compensation reached $1,052M (21.38% of revenue), surpassing total GAAP net income of $904M. Consequently, operating cash flow reflects substantial equity issuance dilution rather than organic operational cash conversion.36
Arm's ROIC sits at 9.38% in FY2026, temporarily weighed down by peak transformation capital expenditures of $545M and upfront compute subsystem engineering. However, ROIC trajectory is improving toward >25% as the asset-light licensing model benefits from Armv9 royalty rate doubling and capex moderates back toward industry benchmarks (4.4% of revenue).
Trailing ROIC of 9.38% is currently below house computed WACC of 16.20% (cost of equity of 16.22% under moderate beta of 2.65), generating an economic profit deficit during the transformation build. Economic value creation will turn positive once expands to 28% in FY2028 and normalizes toward 36% by FY2031.
| Revenue | $1,289,000,000 |
|---|---|
| Cost of revenue | $36,000,000 |
| Gross profit | $1,253,000,000 |
| Operating expenses | $1,155,000,000 |
| Operating income | $98,000,000 |
| Non-operating items and tax | $172,000,000 |
| Net income | $270,000,000 |
| Total assets | $10,703,000,000 |
|---|---|
| Cash | $2,751,000,000 |
| Current assets | $6,236,000,000 |
| Total liabilities | $2,417,000,000 |
| Current liabilities | $1,040,000,000 |
| Shareholders’ equity | $8,286,000,000 |
| Net income | $904,000,000 |
|---|---|
| Operating inflow | $2,205,000,000 |
| Depreciation and amortization | $249,000,000 |
| Stock-based compensation | $1,052,000,000 |
| Operating cash flow | $1,524,000,000 |
| Operating outflow | $681,000,000 |
| Cash available | $3,624,000,000 |
| Beginning cash | $2,085,000,000 |
| Exchange-rate effect | $15,000,000 |
| Investing outflow | $325,000,000 |
| Financing outflow | $548,000,000 |
| Other financing activities | $548,000,000 |
| Ending cash | $2,751,000,000 |
| Investing cash flow | -$325,000,000 |
| Financing cash flow | -$548,000,000 |
Source: SEC EDGAR · Filed 2026-05-26 · SEC EDGAR
| Revenue by business category | Revenue | Share | YoY |
|---|---|---|---|
| Royalty | $2.6B | 53.1% | 20.5% |
| License And Other Revenue | $2.3B | 46.9% | 25.4% |
Source: SEC EDGAR · Filed 2026-05-26 · SEC EDGAR
| Revenue by geography | Revenue | Share | YoY |
|---|---|---|---|
| United States | $1.8B | 35.8% | 2.6% |
| China | $874M | 17.8% | 16.7% |
| Japan | $825M | 16.8% | 178.7% |
| Taiwan | $695M | 14.1% | 10.5% |
| South Korea | $392M | 8% | 21% |
| Other | $373M | 7.6% | 27.3% |
Point-in-time financial data used in the 2026-10-02 analysis.
| Period | Revenue | EBITDA | Net income | Operating cash flow | Free cash flow | Capex | Depreciation and amortization | Stock-based compensation | Share repurchases | Dividends paid | Net debt issuance | Investing cash flow | Financing cash flow | Beginning cash | Ending cash | Cash and investments | Total debt | Operating margin | ROIC | WACC | ROIC − WACC spread |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-03-31 | $2B | $876.8M | $388M | $1.2B | $1.1B | $165M | $201M | $54M | — | $750M | — | -$340M | -$789M | — | — | — | — | 11.9% | — | — | — |
| 2022-03-31 | $2.7B | $962.5M | $549M | $458M | $383M | $75M | $185M | $26M | — | $0 | $50M | -$619M | -$32M | — | $1B | $1.6B | $261M | 25.2% | — | — | — |
| 2023-03-31 | $2.7B | $841.2M | $524M | $739M | $646M | $93M | $170M | $79M | — | $0 | $0 | -$138M | -$42M | $1B | $1.6B | $2.2B | $219M | 25.3% | — | — | — |
| 2024-03-31 | $3.2B | $374M | $306M | $1.1B | $947M | $143M | $162M | $1B | — | — | $0 | -$516M | -$208M | $1.6B | $1.9B | $2.9B | $226M | 3.1% | — | 15.1% | — |
| 2025-03-31 | $4B | $902.9M | $792M | $397M | $178M | $219M | $183M | $820M | — | — | — | -$35M | -$202M | $1.9B | $2.1B | $2.8B | $356M | 20.6% | — | 15.2% | — |
| 2026-03-31 | $4.9B | $1.4B | $904M | $1.5B | $979M | $545M | $249M | $1.1B | — | — | — | -$325M | -$548M | $2.1B | $2.8B | $3.6B | $457M | 18.5% | — | 13.6% | — |
Arm Holdings plc (ARM) trades at 151.5x forward earnings against a peer median of 28.7x. Its EV/EBITDA of 281.3x compares with a peer median of 27.6x. The comparison uses 4 peers: Monolithic Power Systems Inc., Texas Instruments Incorporated, Taiwan Semiconductor Manufacturing Company Limited and ASML Holding N.V., as of 2026-09-29 to 2026-10-01.
Industry average capex-to-revenue is 4.4% and capex-to-depreciation is 1.27x. In contrast, Arm's capital expenditures surged to $545M in FY2026 (11.08% of revenue and 2.31x D&A) from $219M in FY2025 and $143M in FY2024, reflecting an aggressive infrastructure expansion phase into Compute Subsystems (CSS).3
Accelerated adoption of AI inference workloads drives surging hyperscale demand for custom silicon built on Arm Neoverse cores, while rapid Armv9 penetration across premium and mid-tier mobile devices doubles royalty capture rates. In this cycle, licensing revenue compounds at 30%+ and royalty growth exceeds 20% through FY2028-FY2029, while custom silicon revenue scales into a distinct reporting line in FY2028.
Prolonged smartphone stagnation across all market tiers dampens unit volumes, capping royalty revenue growth near 10-13%. Geopolitical export bans restrict access to the Chinese fabless market ($874M in FY2026), while large licensees resist v9 pricing premiums by exploring RISC-V or custom microarchitectures. Concurrently, elevated transformation capex ($545M) and heavy share-based compensation ($1,052M) impair per-share economics.
Arm occupies an indispensable bottleneck position at the foundation of global compute architecture, licensing its ISA and pre-integrated Compute Subsystems across top semiconductor markets in the US ($1,761M in FY2026), China ($874M), Japan ($825M), and Taiwan ($695M). While dominant in mobile with near-total architecture penetration, Arm's ongoing transformation build is repositioning the company as an indispensable provider of turnkey AI datacenter and automotive compute platforms.7
High conviction in the Sell rating is driven by the stark disconnect between the share price of $294.65 as of September 29, 2026 and house intrinsic fair value of $54.92 (-81.36% implied return). Trading at a forward P/E of 151.52x against semiconductor peer medians of ~31x warrants an immediate zero portfolio allocation.34
Portfolio risk management mandates a complete divestment or maximum underweight given the severe valuation mismatch (-81.36% implied return to fair value of $54.92). With an adjusted beta of 2.65 and forward P/E of 151.52x, the stock possesses extreme downside volatility. Hedging strategies utilizing put options or outright position reallocations into undervalued semiconductor peers are strongly advised.
Trading at 151.52x forward P/E and a 436.5% premium to house fair value ($54.92), the stock offers zero margin of safety and severe multiple contraction risk.3
Although FY2028 consensus models 36.2% revenue growth to $8,236M, current valuation already discounts growth exceeding 50% CAGR through 2031, leaving no upside for execution outperformance.1
Despite an unmatched Wide moat and 92.48% gross margins, slowing Q2 royalty growth (13%) and heavy dilution from $1,052M SBC signal an unfavorable risk-reward profile.35
We recommend a Sell on Arm Holdings. At $294.65, the stock trades at an extreme forward P/E of 151.52x, pricing in over 50% sustainable annual earnings growth that far exceeds historical and forecast fundamentals. Our synthesized fair value of $54.92 implies an 81.36% downside, creating an unacceptable risk of capital loss.3
While Arm's Wide economic moat and v9 architectural advantages remain structurally intact, near-term operational realities—including smartphone tier weakness guiding Q2 royalty growth to 13%, high customer concentration (top 3 at 42%), and elevated transformation capex of $545M —cannot justify a 436.5% market premium over intrinsic value.
Capture your own thesis, position size, and follow-up questions. Stays on this device, only you can see it.
The records this analysis drew on, as they stood when it was run.
Not every cited input appears here: internal calculations and intermediate model outputs have no external record, and some citations could not be matched to one.
China generated $874M in FY2026, representing 17.76% of consolidated revenue. Broadened trade bans or licensing embargoes cutting Chinese revenues in half to below $437M would trigger an immediate top-line contraction and margin compression, resulting in an estimated -35.0% fair value impact.37
Reported operating income in FY2026 was $908M on $4,920M revenue (18.46% operating margin), while capex reached $545M (2.31x D&A). Inability to achieve projected operating leverage of 36% due to relentless R&D and subsystem development costs dropping operating margin below 20% would impair cash flow generation with an estimated -24.0% fair value impact.3
Arm trades at an extreme forward P/E of 151.52x, compared to peer ASML at 31.06x and MPWR at 38.63x. Multiple de-rating toward peer medians below 40x would trigger an estimated -45.0% equity value drawdown independent of operational execution.34
A drop of 50% or more indicates strict export restrictions or domestic ISA substitution in Chinese fabless design.
Current:$874M in FY2026 (17.76% of total revenue)
Alert if< $437M annually
Capex failing to moderate toward industry benchmark of 1.27x D&A indicates chronic subsystem design inefficiencies and suppressed FCFF.
Current:2.31x D&A ($545M capex vs $249M D&A in FY2026)
Abrupt reduction without broad-based licensee volume replacement signals insourcing or alternative ISA adoption.
Current:42% of revenue in FY2026
Alert if< 25% or abrupt defection of largest customer (16%)
Failure of operating margin to expand toward projected 28.0% and 36.0% targets confirms persistent R&D and subsystem development cost escalation.
Current:18.46% in FY2026 ($908M operating income on $4,920M revenue)
Alert if< 20.0% of revenue in FY2027-FY2028
| high |
| 12-24 months |
| Arm maintains strict compliance with multilateral export controls and diversifies geographically across the US ($1,761M), Japan ($825M), and Taiwan ($695M).7 |
| Smartphone end-market maturity and consumer volume stagnation across all tiers | medium | 12-18 months | Arm relies on architectural royalty rate doubling via Armv9 to drive double-digit royalty growth despite unit volume headwinds.5 |
Project EPS through the explicit advantage period, fade growth as competition catches up, and discount the full stream at cost of equity.
Apply a terminal P/E to the dated forward EPS path, then discount that future share value back to the analysis date.
Convert the revenue and margin path into after-tax free cash flow, discount the annual per-share amounts and terminal value at WACC, then adjust for signed net debt per current share.
Discounted forecast-period cash flows ($5.17) plus discounted terminal value ($10.59) minus signed per current share (-$2.94) equals the $18.70 lens value shown above. Negative net debt is , so subtracting it raises value.
Add depreciation to net income, subtract maintenance capex, divide by diluted shares, and apply a normalized valuation multiple.
Multiply the peer median PEG by this stock's forecast growth to derive an implied forward P/E, then apply it to forward EPS.
Solve for the growth rate that makes the model value equal the report-date share price.
In the bull case, rapid adoption of custom silicon across hyperscalers (demonstrated by Google Axion and extensive Neoverse core deployments) accelerates revenue expansion well beyond consensus. Royalty growth sustains elevated momentum through FY2029, while custom silicon revenue breaks out as a distinct revenue line in FY2028. Operating margins expand substantially as upfront R&D investments yield high-margin compounding cash flows, driving strong EPS growth.5
Transformation capex for Compute Subsystems must moderate back toward broader semiconductor industry benchmarks to unlock expanding free cash flow.
High concentration among key hyperscalers and mobile OEMs grants major customers substantial bargaining leverage over licensing terms.
Proves whether Arm can successfully scale from pure IP licensing into high-value custom silicon solutions for datacenter AI workloads.
| $10.21B |
| $12.05B |
| $13.74B |
| Revenue growth | 22.9% | 36.2% | 24.0% | 18.0% | 14.0% |
| Operating margin | 24.0% | 28.0% | 31.0% | 34.0% | 36.0% |
| Operating income | $1.45B | $2.31B | $3.17B | $4.10B | $4.95B |
| Tax rate | 21.9% | 21.9% | 21.0% | 21.0% | 21.0% |
| NOPAT | $1.13B | $1.80B | $2.50B | $3.24B | $3.91B |
| Reinvestment | $396.81M | $540.53M | $625.28M | $647.38M | $703.29M |
| Reinvestment rate (of NOPAT) | 35.0% | 30.0% | 25.0% | 20.0% | 18.0% |
| Free cash flow to firm | $736.93M | $1.26B | $1.88B | $2.59B | $3.20B |
| Terminal growth | 3.5% | 3.5% | 3.5% | 3.5% | 3.5% |
Arm maintains a pristine liquidity profile with $2,751M in cash and equivalents against total debt of just $485M, providing a net cash buffer exceeding $2.26B. Arm does not pay a regular dividend and reallocates cash into internal R&D and subsystem development. Capital allocation discipline must address ongoing share dilution: diluted share count reached 1,068M shares in FY2026, with share dilution modeled at 1.2% in FY2027 and 1.0% in FY2028 to absorb employee share grants.
FY2026 SBC was $1,052M (21.38% of revenue), compared to GAAP net income of $904M and operating cash flow of $1,524M.
Reported operating cash flow overstates cash generation per share, as ongoing employee equity grants create perpetual share dilution across 1,068M diluted shares.
FY2026 capex rose to $545M, up from $219M in FY2025 and $143M in FY2024, far outpacing the semiconductor industry average capex-to-depreciation ratio of 1.27x.
Free cash flow was constrained to $979M; cash flow compounding depends on capex normalizing toward the industry capex-to-revenue benchmark of 4.4%.
Arm trades at a forward P/E of 151.52x at a share price of $294.65, compared to peer ASML at 31.06x and MPWR at 38.63x.
Current equity pricing reflects a 436.5% premium over house intrinsic fair value ($54.92), leaving zero margin of safety for operational execution delays.
| Margin |
|---|
| ARM | Arm Holdings plc | $314.7B | 151.5x | 61.0x | 281.3x | 13.4% | — |
| MPWR | Monolithic Power Systems Inc. | $66.2B | 38.6x | 20.2x | 64.8x | 22.0% | 31.0% |
| TXN | Texas Instruments Incorporated | $255.8B | 26.3x | 13.1x | 27.6x | 35.2% | 42.6% |
| TSM | Taiwan Semiconductor Manufacturing Company Limited | $2.37T | 20.9x | 0.5x | 5.2x | 40.0% | 60.3% |
| ASML | ASML Holding N.V. | $702.1B | 31.1x | 19.9x | 53.9% | 37.1% |
| negative |
| Extended smartphone replacement cycles across low, mid, and high tiers cap unit shipment volumes, shifting growth dependence onto per-device architectural royalty rate expansion. |
| Geopolitical Export Controls and Semiconductor Nationalism | negative | Bilateral trade tensions between the United States and China jeopardize cross-border IP licensing, directly impacting China revenue which reached $874M (17.76% of total revenue) in FY2026. |
| Substantial multiple de-rating would reduce extreme speculative froth but remain well above intrinsic value, requiring patient observation rather than capital commitment. |
| At or Below House Fair Value ($54.92) | Underwrite Fundamental Re-entry Only at Margin of Safety | Only a severe de-rating aligning share price with intrinsic earning power and a normalized forward P/E would justify initiating fundamental exposure. |
| > 2.50x D&A |
| Re-evaluate free cash flow conversion model as chronic subsystem development expenses suppress returns on capital.3 |
| China Revenue Quarterly Contribution | < $175M in any quarter (annualized < $700M) | Model permanent geographic impairment in China and reduce long-term terminal revenue targets.7 |
| Forward P/E Multiple Compression | < 60.0x Forward P/E | Audit whether multiple contraction is driven by broad market de-rating or fundamental microarchitecture loss, maintaining Sell discipline.3 |
